Druggability Technologies Archives

DRGT USA Announces Appointment of Dr. Elizabeth Manning Duus, as Executive Director of Clinical Development

NEW YORK, Feb. 5 (Korea Bizwire) — Druggability Technologies USA today announced the expansion of the clinical team, with the addition of Dr. Elizabeth Manning Duus, who has been named Executive Director, Clinical Development. Druggability Technologies USA has been engaged by Druggability Technologies Holdings (DRGT) to assist with the clinical development of all human trials. [...]

Druggability Technologies USA Announces Appointment of John E. Friend II, M.D. as Chief Medical Officer

NEW YORK, Dec. 6 (Korea Bizwire) — Druggability Technologies USA today announced that Dr. John E. Friend II has been named as Chief Medical Officer. Druggability Technologies USA has been engaged by Druggability Technologies Holding (DRGT) to assist with the clinical development of all human trials for DRGT. DRGT is a specialty pharmaceutical company that [...]